Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: Specific effect of HAART on Neopterin

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 5, 2000, Pages 832-834

  Amirayan Chevillard, N ^a   Tissot Dupont, H ^a   Obadia, Y ^a   Gallais, H ^a   Mege, J L ^a   Capo, C ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 2 RECEPTOR; NEOPTERIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY CELL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; STEM CELL;

ADULT; ANTI-HIV AGENTS; ANTIGENS, CD; BIOLOGICAL MARKERS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPTERIN; REAGENT KITS, DIAGNOSTIC; RECEPTORS, IGE; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SENSITIVITY AND SPECIFICITY;

EID: 0033835255     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.7.5.832-834.2000     Document Type: Article

References (21)

1. Impact of highly active antiretroviral therapy on cytokine production and monocyte subsets in HIV-infected patients
2. Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection. Correlations to clinical immunologic and virologic parameters
3. + T cell homeostasis and function in advanced HIV disease
4. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: Quality control procedures
5. Circulating cytokine balance and activation markers of leucocytes in Q fever
6. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine
7. + lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients
8. Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy
9. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements
10. Serum increases and lymphoid cell surface losses of IL-2 receptor CD25 in HIV-1 infection: Distinctive parameters of HIV-1-induced changes
11. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma
12. Serum neopterin changes in HIV-1 infected subjects: Indicator of significant pathology, CD4 T cell changes and the development of Aids
13. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients
14. Declining morbidity and mortality among patients with advanced immunodeficiency virus infection
15. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes
16. Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users
17. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection
18. 2-microglobulin
19. CD14(low)CD16(high): A cytokine-producing monocyte subset which expands during human immunodeficiency virus infection
20. Markers predicting progression of human immunodeficiency virus-related disease
21. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals